ConvaTec
Sector/industry:
Wound care and therapeutic products
Company description:
ConvaTec is a leading developer and marketer of innovative medical technologies. With four key business divisions, ostomy care, wound therapeutics, continence and critical care and infusion devices, ConvaTec products support health care professionals from the hospital to the community health setting. The company has operations in over 90 countries serving consumers and health care professionals on six continents.

Nordic Capital Fund´s VI and VII, together with Avista Capital partners acquired Convatec from Bristol Myers Squibb in August 2008.

After the acquisition by Nordic Capital, ConvaTec has integrated Unomedical, a leading manufacturer of single-use medical devices based in Copenhagen and a Nordic Capital portfolio company since 2003.

Management: David I. Johnson, CEO
George Kegler, CFO
Board of Directors: Toni Weitzberg, Chairman
David Burgstahler
Thompson Dean
David I. Johnson
Kristoffer Melinder
Key Information
Revenues 2008: EUR 1,150 million
Employees: 8,000
Ownership: Nordic Capital Fund VI and Nordic Capital Fund VII, controlling shareholding
Date of investment : 2008
Web: www.convatec.com